Development of Probiotics & LBPs to Support Infant & Women’s Health with Cecile Vernochet

Описание: Development of Probiotics & Live Biotherapeutic Products LBPs to Support Infant & Women’s Health with Cecile Vernochet
Cecile Vernochet, Ph.D., is Discovery Project Lead at Gates Medical Research Institute, a role she's held since 2020. She focuses on supporting scientific discoveries, program development and clinical trials for probiotic nutritional supplements in LMICs and advising on women's health product initiatives for the Gates Foundation. With over 20 years of experience in biological discovery research, Cecile's preclinical expertise spans stem cell biology to complex animal models for metabolic diseases such as obesity, type 2 diabetes, and NAFLD/NASH. In pharmaceutical field , she led a target discovery and validation laboratory at Pfizer, managing projects from preclinical stages through Phase 2B trials. Cecile earned her Bachelor's in Biochemistry and Molecular Biology and a Ph.D. in Physiology from the University of Science, Nice, France. Her PhD research was supported by French National Agency against HIV. She extended her research expertise by completing post-doctoral fellowship at BUMC and Harvard affiliated Joslin Diabetes Center in Boston, USA.

Further reading:
1. Frontiers | Navigating regulatory and analytical challenges in live biotherapeutic product development and manufacturing
2. Challenges and Opportunities in Live Biotherapeutic Products Development - Creative Biolabs
3. The Complexities of Regulatory Approval for Live Biotherapeutic Products Unravelled - Microbiome Times Magazine
4. Frontiers | Navigating regulatory and analytical challenges in live biotherapeutic product development and manufacturing
5. Rouanet A, Bolca S, Bru A, et al. Live Biotherapeutic Products, A Road Map for Safety Assessment. Front Med (Lausanne). 20201.
6. Ducarmon, Quinten R et al. “Opportunities and Challenges in Development of Live Biotherapeutic Products to Fight Infections.” The Journal of infectious diseases (2021)